CoChat

Spectrum of Fibrotic Lung Diseases

Wijsenbeek, Marlies, Cottin, Vincent · 2020 · New England Journal of Medicine

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

This review covers fibrotic pulmonary diseases. Although idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases other than IPF. The biology, clinical presentation, and treatment of the more common disorders are discussed.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmra2005230

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Research works printed but not linked: 1

  1. George PM, Spagnolo P, Kreuter M, et al. Progressive fibrosing interstitial lung disease; consensus recommendations, clinical uncertainties and research priorities. Lancet Respir Med (in press).

Cited by

See all 781

Metadata

Authors
Wijsenbeek, M., & Cottin, V.
Affiliations
Lyon 1 Université (FR)
Venue
New England Journal of Medicine
Published
2020-09-03
Volume
383
Issue
10
Pages
958-968
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3082667512
Cited by
736
References
52
Citations by year
2026: 81 · 2025: 153 · 2024: 138 · 2023: 145 · 2022: 117 · 2021: 95 · 2020: 7
FWCI
12.75
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords
fibrotic lung disease, idiopathic pulmonary fibrosis, pulmonary fibrosis, disease biology, clinical features, treatment
MeSH terms
Algorithms, Humans, Lung, Oxygen Inhalation Therapy, Pulmonary Fibrosis, Prevalence, Immunomodulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spectrum of Fibrotic Lung Diseases. https://app.cochat.ai/papers/10.1056/nejmra2005230
The paper
Wijsenbeek, M., & Cottin, V. (2020). Spectrum of Fibrotic Lung Diseases. New England Journal of Medicine. https://doi.org/10.1056/nejmra2005230

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.